While fundamentally there is nothing wrong with JFL and its business model, all good things seem to have been priced into the valuation for now which may lead to the stock underperforming the broader market in the near to medium term.

Though the scrip is holding up well at Rs 7105, a further continuation of the MEA strike may have an impact on the scrip going forward.

The repeat order contains 10 units of 2.1MW wind turbine generators aggregating a total 21MW of capacity.

With the entry in this therapeutic segment, one can see good growth prospects for the company.

The US Gabapentin market is supposed to be US$220 Million for twelve months ending June 2011 according IMS.

FAG is a manufacturer of ball bearings in India, and is one of the leading OEM suppliers to the automotive and the industrial sector as well as the Indian Railways.

Ind-Swift Laboratories is available at a PE of 2.46x, which is quite low. With consistent dividends (FY11 dividend at Rs 1 per share on FV of Rs 10), it makes sense to grab this scrip.

Direct beneficiary of an expansion spree by tyre companies in India

In Q1FY12, where many companies saw deceleration in their growth, SCL’s revenues & profits grew by 41% and 43%, to Rs 54.43 cr & Rs 2.77 cr respectively.